Clinical Trial Update: Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing long-term use of viltolarsen in boys with Duchenne muscular dystrophy in clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Viltolarsen (viltolarsen)

Snippet

Sponsor: NS Pharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 4 | Status: ACTIVE_NOT_RECRUITING